Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Scientific Indications for Priorities of SARS-CoV-2 Vaccination in Patients with Cancer

Aired live on 25 May 2021

ESMO-CoV-2-Vaccine-Webinar-Series-Webinar-Banners_16-February-1000x250px

Scientific Indications for Priorities of SARS-CoV-2 Vaccination in Patients with Cancer

Chair: Florian Scotté
Speakers: Christina Ruhlmann, Emanuela Romano, Giovanni Boniolo

Learning objectives: 

  • To understand different considerations important for SARS-CoV-2 vaccination prioritisation from the aspects of general population vs patients with cancer
  • To understand different considerations in prioritising subgroups of patients with cancer
  • To understand different ethical challenges posed by SARS-CoV-2 vaccination

The programme was designed to offer expert opinion exchange and provide some considerations on key economic, ethical and societal aspects of prioritising the SARS-CoV-2 vaccination, as well as the balance between personal and societal freedoms, and special issues in vulnerable patient groups.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.